{
    "SPADE_UN_27247": {
        "Sequence Information": {
            "Peptide Name": "Peptide P [L6A]",
            "Sequence": "KWKSFAKTFKSAKKTVLHTALKAISS",
            "Sequence Length": 26,
            "Biological Activity": [
                "Anti-Gram-",
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides",
                    "Pubmed ID": "17158938",
                    "Reference": "Antimicrob Agents Chemother. 2007;51:1398–1406",
                    "Author": "Chen Y, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/17158938"
                },
                {
                    "Title": "Studies on mechanism of action of anticancer peptides by modulation of hydrophobicity within a defined structural framework.",
                    "Pubmed ID": "21252288",
                    "Reference": "Mol Cancer Ther. 2011;10:416-426",
                    "Author": "Huang Y, Wang XF, Wang HY, Liu Y, Chen Y",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/21252288"
                },
                {
                    "Title": "Specificity and mechanism of action of alpha-helical membrane-active peptides interacting with model and biological membranes by single-molecule force spectroscopy.",
                    "Pubmed ID": "27363513",
                    "Reference": "Sci Rep. 2016;6:29145",
                    "Author": "Sun S, Zhao G, Huang Y, Cai M, Shan Y, Wang H, Chen Y",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/27363513"
                }
            ],
            "Mass": 2907.45,
            "PI": 10.78,
            "Net Charge": 8,
            "Hydrophobicity": -0.29,
            "Frequent Amino Acids": "KAS",
            "Absent Amino Acids": "CDEGMNOPQRUY",
            "Basic Residues": 8,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 10,
            "Polar Residues": 16,
            "Positive Residues": 8,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_27247",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_27003",
                    "Similarity": 1.0,
                    "Sequence": "KWKWKPGKWKWK"
                },
                {
                    "SPADE_ID": "SPADE_UN_27247",
                    "Similarity": 1.0,
                    "Sequence": "KWKSFAKTFKSAKKTVLHTALKAISS"
                },
                {
                    "SPADE_ID": "SPADE_N_06306",
                    "Similarity": 0.9615384615384616,
                    "Sequence": "KWKSFAKTFKSAKKTVAHTALKAISS"
                }
            ],
            "Hemolytic Activity": "Human erythrocytes:<5% Hemolysis=500 µM,Mouse fibroblasts 3T3-L1:50% Cell death=87.3 µM",
            "Target Organism": "Pseudomonas aeruginosa PAO1(MIC=125µg/ml),Pseudomonas aeruginosa WR5(MIC=250µg/ml),Pseudomonas aeruginosa PAK(MIC=250µg/ml),Pseudomonas aeruginosa PA14(MIC=500µg/ml),Pseudomonas aeruginosa M2(MIC=250µg/ml),Pseudomonas aeruginosa CP204(MIC=125µg/ml),Human lung carcinoma A549(IC50=53.1±0.06µM),Human melanoma A375(IC50=58.7±0.08µM),Human breast adenocarcinoma MCF-7(IC50=62.3±0.08µM),Human colon adenocarcinoma SW1116(IC50=>83.6µM),Human rhabdomyosarcoma(IC50=>83.6µM),Human lung carcinoma H1299(IC50=14.0±0.02µM),Mouse skin melanoma B16(IC50=62.6±0.07µM),Human cervical carcinoma HeLa(IC50=58.6±0.07µM),Staphylococcus aureus ATCC 25923(MIC=>125µM),Staphylococcus epidermidis ATCC 12228(MIC=64µM),Pseudomonas aeruginosa ATCC 27853(MIC=125µM),Escherichia coli ATCC 25922(MIC=64µM),Human gastric cancer SGC-7901(IC50=78.87µM)"
        }
    }
}